Vialwirebiotech, curated
September 30, 2026, 7:42 PM
August 21, 2026
- 5:45 PM · Nikkei Asia5:45 PMWorld-first virus therapy for esophageal cancer debuts in Japan — Nikkei Asia
- 3:22 PM · Bloomberg — Technology3:22 PMKhosla Ventures Bets on AI’s Next Frontier: Science — Bloomberg — Technology
- 12:00 PM · BioWorld12:00 PMEuropean regulators recall Amgen’s rare disease drug Tavneos — BioWorld
- 9:10 AM · PharmaVoice9:10 AMTyra’s one-drug, three-indication bet nears its first phase 2 test — PharmaVoice
- 9:00 AM · BioWorld
- 9:00 AM · Labiotech (EU)9:00 AMThe cost of waiting: what licensing a biotech asset early really saves you — Labiotech (EU)
- 9:00 AM · BioWorld9:00 AMChina NMPA clears Akeso’s AK-157D1 for clinic in solid tumors — BioWorld
- 9:00 AM · BioWorld9:00 AMMatwings announces China clinical trial clearance for Gensci-148 — BioWorld
- 9:00 AM · BioWorld9:00 AMDeepcure describes new STAT6 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMDeciphera identifies new CDK12 and/or CDK13 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMRoche synthesizes new apelin receptor agonists — BioWorld
- 9:00 AM · BioWorld9:00 AMBioarctic and Mesenkia collaborate in glioblastoma — BioWorld
- 8:02 AM · Drug Discovery World8:02 AMPartnership supports radiopharmaceutical solid tumour development — Drug Discovery World
- 6:59 AM · Pharmaceutical Technology6:59 AMRoche commits $750m to double Oregon-based US manufacturing capacity — Pharmaceutical Technology
- 5:52 AM · Pharmaceutical Technology5:52 AMEli Lilly’s weekly insulin jab Onswik set for NHS use if approved — Pharmaceutical Technology
- 4:27 AM · Pharmaceutical Technology4:27 AMCharles River and MVC to develop enterovirus vaccine — Pharmaceutical Technology
- 2:15 AM · Bloomberg — Technology2:15 AMStevenage Braces for Life After GSK as Drugmaker Moves to Cambridge — Bloomberg — Technology
August 20, 2026
- 12:00 PM · BioWorld12:00 PMFDA clears Ultragenyx one-time gene therapy for ultra-rare GSDIa — BioWorld
- 10:00 AM · SCMP — Tech10:00 AMChinese stem cell therapy reverses heart failure in 90% of patients in landmark trial — SCMP — Tech
- 9:00 AM · BioWorld9:00 AMMedigen Vaccine Biologics advances enterovirus vaccine — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMAmplitude Therapeutics and Lilly collaborate on taRNA vaccines — BioWorld
- 9:00 AM · BioWorld9:00 AMEngine Biosciences patents new dual Wee1/PKMYT1 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMHansoh discovers new CALCR/AMY3 agonists — BioWorld
- 9:00 AM · BioWorld9:00 AMJocasta signs α-klotho license agreement with UCSF — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMShenghe Wanwu Biotechnology describes new TNF-α inhibitors — BioWorld
- 8:00 AM · Drug Discovery World8:00 AMBIOCAPTIVA Chair appointment to steer global growth — Drug Discovery World
- 7:00 AM · Drug Discovery World7:00 AMCCDC launches Innovation Fund — Drug Discovery World
- 5:26 AM · Drug Discovery World5:26 AMInsilico advances virtual cell research — Drug Discovery World
- 4:51 AM · Pharmaceutical Technology4:51 AMSandboxAQ introduces AQPotency for virtual drug screening — Pharmaceutical Technology